Levobupivacaine is a local anesthetic used to numb specific areas of the body during surgery, dental procedures, or pain management treatments so patients don't feel pain in that region.[2] Chirocaine is currently approved and in use across 20 indications[4].[1]
Chirocaine is one of 316 small molecule programs targeting Cleft Palate. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
2828 competitors in Breast Cancer
Chirocaine
DATROWAY
Megace
Cymbalta
MS Contin
Zolymbus
Blenoxane
Lupron
Zinecard
Effexor
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Aug 5, 1999
CHIROCAINE
NDA NDA020997
Sources
Details